JAY M MOYES
CIK 1191062 · Chief Financial Officer · last filed 2026-07-07
JAY M MOYES is a Chief Financial Officer who has filed 82 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for BCDA, was dated Jul 7, 2026. Across all open-market trades the lifetime net is −$7.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $822.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$822.8K
10
82
-$7.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCDA | Director | — | $0.78 | — | $0 | 6 | 2026-07-07 |
| PBYI | Director | 58,322 | $7.97 | $464.8K | -$919.6K | 22 | 2026-06-15 |
| SINT | Director | 4,000 | $1.56 | $6.2K | $13.7K | 2 | 2026-02-25 |
| BioCardia, Inc. (BCDAW) Delisted | Director | 54,267 | $0.01 | $331 | $0 | 10 | 2023-10-19 |
| SERA | Chief Financial Officer | 35,630 | $2.03 | $72.3K | $0 | 3 | 2023-03-07 |
| ACHV | Director | — | $6.18 | — | $0 | 6 | 2022-06-01 |
| ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted | Director | — | — | — | $0 | 1 | 2017-08-03 |
| Sintx Technologies, Inc. (AMDA) Delisted | Chief Financial Officer | 66,562 | — | — | $0 | 1 | 2014-02-21 |
| OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Director | 26,500 | — | — | $0 | 8 | 2014-02-07 |
| MYGN | Chief Financial Officer | 52,512 | $5.32 | $279.4K | -$6.29M | 18 | 2007-10-16 |
Recent Filings
82 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-07 | BCDA | Grant (A) | — | $0 | EDGAR |
| 2026-06-15 | PBYI | Mixed | +5,000 | -$158.8K | EDGAR |
| 2026-06-12 | PBYI | Notice (144) | −22,000 | -$159.7K | EDGAR |
| 2026-02-25 | SINT | Buy (P) | +1,000 | $2.9K | EDGAR |
| 2025-12-10 | BCDA | Grant (A) | — | $0 | EDGAR |
| 2025-08-27 | SINT | Buy (P) | +3,000 | $10.8K | EDGAR |
| 2025-06-17 | PBYI | Sell (S) | −22,000 | -$74.8K | EDGAR |
| 2025-06-13 | PBYI | Notice (144) | −22,000 | -$74.8K | EDGAR |
| 2025-06-13 | PBYI | Grant (A) | +27,000 | $0 | EDGAR |
| 2024-10-16 | BCDA | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.